Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Leyes y legislación
22
Patentes de invención
22
Propiedad industrial
15
Patentes
11
Derechos de autor
8
Marcas de fábrica
5
Historia
4
México
3
Transferencia de tecnología
3
Aspectos ambientales
2
Biotecnología
2
Biotecnología agrícola
2
Ciencia
2
Criptografía
2
Genes
2
Ingeniería genética
2
Literatura española
2
Marcas
2
Monopolios
2
PATENTES
2
PATENTS
2
Patents
2
Propiedad intelectual
2
Universidades
2
ACADEMIC PRODUCTION
1
ACADEMIC WOMEN
1
ANÁLISIS BIBLIOMÉTRICO
1
Acuerdos (Derecho)
1
Administración pública
1
Agricultura
1
-
9441por Chang, Ming, Johnston , Selena, Seilie, Annette M., Hergott, Dianna, Murphy, Sean C.“…Seventy-eight DBS samples from persons residing in endemic regions with sub-patent infections were tested in pools and deconvoluted to identify positive cases. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9442por Chen, Rencong, Feng, Ruijia, Jiang, Suiting, Chang, Guangqi, Hu, Zuojun, Yao, Chen, Jia, Benyuan, Wang, Shenming, Wang, Siwen“…CONCLUSIONS: For PTS patients with iliofemoral vein occlusion but patent inflow, iliofemoral vein stent implantation is a more efficient therapeutic option than iliofemoral vein balloon dilation with iliac vein stent implantation for PTS patients.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9443por Chen, Li, Duan, Hong-zhou, Zhang, Chen, Li, Gang, Wu, Yong-tao, Wang, Dong, Li, Xiao-yan“…METHODS: Based on whether CoA was combined with a large ventricular septal defect (VSD) or patent ductus arteriosus (PDA), the patients were divided into a simple CoA group (n = 15) and a complex CoA group (n = 13). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9444por Dang, Lei, Zhang, Chunbo, Su, Biru, Ning, Na, Huang, Qiuling, Zhou, Su, Wu, Meng, Ma, Wenqing, Wang, Man, Cui, Pengfei, Li, Yan, Wang, Shixuan“…BACKGROUND: Zishen Yutai (ZSYT) pill, a patent Chinese medicine, has been widely used in the treatment of infertility, abortion, and adjunctive treatment of in vitro fertilization (IVF) for decades. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9445por Wang, Li-Kuan, Zhang, Xiang, Wu, Hai-Yin, Cheng, Tong, Xiong, Guo-Li, Yang, Xu-Dong“…When presented with patients with equally patent nostrils, selection of the nostril to use for intubation is an important decision for facilitating intubation. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9446por Gwaltney, Chad, Stokes, Jonathan, Aiudi, Anthony, Mazar, Iyar, Ollis, Sarah, Love, Emily, Karaa, Amel, Houts, Carrie R., Wirth, R. J., Shields, Alan L.“…METHODS: The PMMSA was completed as a daily diary for approximately 14 weeks by individuals in a Phase 2 randomized, placebo-controlled crossover trial evaluating the safety, tolerability, and efficacy of subcutaneous injections of elamipretide in patents with mitochondrial disease. In addition to the PMMSA, performance-based assessments, clinician ratings, and other PRO measures were also completed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9447por Tamulaitis, G, Streun, M, Tsoumpas, C, Lerche, C, Auffray hillemanns, E, Chipaux, R, Pizzichemi, M, Kratochwil, N, Yvon, D, Morel, C, Vasilyev, A, Rinaldi, D, Padulano, V E“…After this success Crystal clear has continued its investigation on new scintillators and the understanding of scintillation mechanisms and light transfer properties in particular : The understanding of cerium ion as activator, The development of LuAP, LuYAP crystals for medical imaging applications, (CERN patent) Investigation of Ytterbium based scintillators for solar neutrinos spectroscopy and more recently on LuAG crystals. …”
Publicado 2002
Enlace del recurso
-
9448“…The incidence rates of patent ductus arteriosus (PDA), pulmonary hypertension, and tricuspid regurgitation were significantly higher in the BPD group than in the non-BPD group (P < 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9449por Viola, G, Bandino, S, Zirolia, D, Amadori, F, Sanna, G D, Fadda, M, Lorenzoni, G, Merella, P, Berne, P M, Casu, G“…Mean entrance points identified was 2,6±0,84. In 5 patents (50%), after ablation a modification in the refractory period of the left ventricular myocardium was observed. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9450“….); 80% of the cases were in sinus rhythm, 53% had a normal LA size, and the mean CHADS2-VA2SC score was 1.5 ± 1.6. One patent fossa ovalis and one septal pouch of the left atrium were seen. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9451por Campbell, Helen Eloise“…Additional data considered and included in the formulary review process are clinical attributes, patent expirations/generic competition, off-label or pending indications, and pharmacoeconomic data. …”
Publicado 2005
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9452“…Smith: Consulting Fee; Self; Horizon Therapeutics plc, Viridian, Lundbeck. Other; Self; US patents covering the use of IGF-1 receptor inhibitors in TED which are held by UCLA and the Lundquist Institute. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9453“…. - Founder, stockholder, scientific advisory board member, member of the board of directors for ARase Therapeutics, Inc. - Coholder of U.S. Patent. Recent studies have identified oncohistones, which are encoded by histone genes that harbor missense mutations, as a new class of cancer drivers. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9454por Al Maddallah, Walaa S, Bhat, Yasser A, Al Mesned, Abdulrahman, Al Qwaee, Abdullah, Hassan, Mohammad Ahmad, Al Akhfash, Ali“…Among the congenital cardiac defects, an isolated atrial septal defect (ASD) was seen in 66 (18.5%), isolated patent ductus arteriosus in 50 (14.2%), and ventricular septal defect in 21 (5.9%). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9455por Prosty, Connor, Katergi, Khaled, Nguyen, Alex, Luo, Owen, Sorin, Mark, Cherniak, Vladimir, Sebag, Michael, Demir, Koray, McDonald, Emily, Lee, Todd C, Cheng, Matthew“….: Board Member|Kanvas Biosciences, Inc.: Pending patents|Kanvas Biosciences, Inc.: Ownership Interest|Merck: Honoraria|nomic bio: Advisor/Consultant|nomic bio: Stocks/Bonds|Pfizer: Honoraria|Scynexis Inc.: Grant/Research Support|Takeda: Advisor/Consultant|Takeda: Honoraria…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9456por Lieu, Anthony, Harrison, Luke B, Harel, Josée, Cheng, Matthew, Domingo, Marc-Christian“….: Board Member|Kanvas Biosciences, Inc.: Pending patents|Kanvas Biosciences, Inc.: Ownership Interest|Merck: Honoraria|nomic bio: Advisor/Consultant|nomic bio: Stocks/Bonds|Pfizer: Honoraria|Scynexis Inc.: Grant/Research Support|Takeda: Advisor/Consultant|Takeda: Honoraria…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9457por Kim, Hyungtae, Sung, Si Chan, Chang, Yun Hee, Jung, Wonkil, Lee, Hyoung Doo, Park, Ji Ae, Huh, Up“…MATERIALS AND METHODS: Forty-four patients with TOF/PA with patent ductus arteriosus (PDA) who underwent staged repair from June 1991 to October 2010 were included in this retrospective study. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9458por Di Stefano, Andrea F. D., Rusca, Antonio, Radicioni, Milko M., Loprete, Luca, Binelli, Daniela, Caccia, Giorgio, Cometti, Barbara“…BACKGROUND AND OBJECTIVE: Highly purified human menotrophin and urofollitrophin preparations obtained from human urine via a novel patented purification method have been tested over a timeframe of 14 years in the studies presented in this article. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9459por Xiong, Shuting, Wang, Ying, Yao, Mingdong, Liu, Hong, Zhou, Xiao, Xiao, Wenhai, Yuan, Yingjin“…BACKGROUND: 21-deoxycortisol (21-DF) is the key intermediate to manufacture pharmaceutical glucocorticoids. Recently, a Japan patent has realized 21-DF production via biotransformation of 17-hydroxyprogesterone (17-OHP) by purified steroid 11β-hydroxylase CYP11B1. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
9460“…Objective: Xingnaojing injection (XNJ) is derived from An-Gong-Niu-Huang pill, a well-known traditional Chinese patent medicine, which is widely used for stroke. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto